RNA sequencing analysis of hepatocellular carcinoma identified oxidative phosphorylation as a major pathologic feature.


Journal

Hepatology communications
ISSN: 2471-254X
Titre abrégé: Hepatol Commun
Pays: United States
ID NLM: 101695860

Informations de publication

Date de publication:
08 2022
Historique:
revised: 12 02 2022
received: 01 11 2021
accepted: 03 03 2022
pubmed: 29 3 2022
medline: 28 7 2022
entrez: 28 3 2022
Statut: ppublish

Résumé

Dysregulation of expression of functional genes and pathways plays critical roles in the etiology and progression of hepatocellular carcinoma (HCC). Next generation-based RNA sequencing (RNA-seq) offers unparalleled power to comprehensively characterize HCC at the whole transcriptome level. In this study, 17 fresh-frozen HCC samples with paired non-neoplastic liver tissue from Caucasian patients undergoing liver resection or transplantation were used for RNA-seq analysis. Pairwise differential expression analysis of the RNA-seq data was performed to identify genes, pathways, and functional terms differentially regulated in HCC versus normal tissues. At a false discovery rate (FDR) of 0.10, 13% (n = 4335) of transcripts were up-regulated and 19% (n = 6454) of transcripts were down-regulated in HCC versus non-neoplastic tissue. Eighty-five Kyoto Encyclopedia of Genes and Genomes pathways were differentially regulated (FDR, <0.10), with almost all pathways (n = 83) being up-regulated in HCC versus non-neoplastic tissue. Among the top up-regulated pathways was oxidative phosphorylation (hsa00190; FDR, 1.12E-15), which was confirmed by Database for Annotation, Visualization, and Integrated Discovery (DAVID) gene set enrichment analysis. Consistent with potential oxidative stress due to activated oxidative phosphorylation, DNA damage-related signals (e.g., the up-regulated hsa03420 nucleotide excision repair [FDR, 1.14E-04] and hsa03410 base excision repair [FDR, 2.71E-04] pathways) were observed. Among down-regulated genes (FDR, <0.10), functional terms related to cellular structures (e.g., cell membrane [FDR, 3.05E-21] and cell junction [FDR, 2.41E-07], were highly enriched, suggesting compromised formation of cellular structure in HCC at the transcriptome level. Interestingly, the olfactory transduction (hsa04740; FDR, 1.53E-07) pathway was observed to be down-regulated in HCC versus non-neoplastic tissue, suggesting impaired liver chemosensory functions in HCC. Our findings suggest oxidative phosphorylation and the associated DNA damage may be the major driving pathologic feature in HCC.

Identifiants

pubmed: 35344307
doi: 10.1002/hep4.1945
pmc: PMC9315135
pii: 02009842-202208000-00027
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2170-2181

Informations de copyright

© 2022 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.

Références

Nature. 2014 Oct 30;514(7524):628-32
pubmed: 25119024
Trends Cancer. 2017 Nov;3(11):768-779
pubmed: 29120753
Hepatology. 2021 Jan;73 Suppl 1:4-13
pubmed: 32319693
Bioinformatics. 2013 Jul 15;29(14):1830-1
pubmed: 23740750
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Gut. 2019 Nov;68(11):2019-2031
pubmed: 31227589
N Engl J Med. 2011 Sep 22;365(12):1118-27
pubmed: 21992124
Semin Oncol. 2012 Aug;39(4):473-85
pubmed: 22846864
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Cell Cycle. 2011 Dec 1;10(23):4047-64
pubmed: 22134189
J Clin Invest. 2016 Oct 3;126(10):3739-3757
pubmed: 27571409
PLoS One. 2011;6(10):e26168
pubmed: 22043308
J Surg Res. 2019 Feb;234:343-352
pubmed: 30527495
J Hepatol. 2017 Oct;67(4):727-738
pubmed: 28532995
Int J Cancer. 2016 May 1;138(9):2231-46
pubmed: 26595876
Genome Biol. 2014;15(12):550
pubmed: 25516281
Front Physiol. 2020 Oct 06;11:574082
pubmed: 33123030
Nat Rev Cancer. 2006 Sep;6(9):674-87
pubmed: 16929323
Int J Mol Sci. 2020 Jul 25;21(15):
pubmed: 32722385
J Hepatol. 2019 Sep;71(3):616-630
pubmed: 31195064
Hepatol Commun. 2022 Aug;6(8):2170-2181
pubmed: 35344307
Am J Transplant. 2021 Feb;21 Suppl 2:208-315
pubmed: 33595192
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Cell. 2019 Oct 31;179(4):829-845.e20
pubmed: 31675496
Cell. 2017 Jun 15;169(7):1327-1341.e23
pubmed: 28622513
Cell Commun Signal. 2018 Feb 05;16(1):6
pubmed: 29402287
Int J Biochem Cell Biol. 2015 Jul;64:75-80
pubmed: 25817041
EBioMedicine. 2019 Feb;40:457-470
pubmed: 30598371
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Apr;1864(4):489-499
pubmed: 30639733
BMC Bioinformatics. 2009 May 27;10:161
pubmed: 19473525
Gastroenterology. 2015 Oct;149(5):1226-1239.e4
pubmed: 26099527
Oncotarget. 2017 May 30;8(22):35973-35983
pubmed: 28415592
F1000Res. 2015 Dec 30;4:1521
pubmed: 26925227
Curr Genomics. 2010 Jun;11(4):261-8
pubmed: 21119890
Nat Genet. 2002 Aug;31(4):339-46
pubmed: 12149612
Int J Mol Sci. 2018 Mar 23;19(4):
pubmed: 29570697
Mol Carcinog. 2011 Apr;50(4):235-43
pubmed: 21465573
Hepatology. 2015 Jan;61(1):191-9
pubmed: 25142309
Oncotarget. 2016 Jun 21;7(25):38487-38499
pubmed: 27220887
J Clin Invest. 2017 Nov 1;127(11):4118-4123
pubmed: 28990936
Hepatology. 2005 Oct;42(4):809-18
pubmed: 16175600
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15089-94
pubmed: 11752456
Cancer Res. 2002 Jul 15;62(14):3939-44
pubmed: 12124323
Gastroenterology. 2004 Nov;127(5 Suppl 1):S5-S16
pubmed: 15508102
NPJ Precis Oncol. 2018 Nov 15;2:25
pubmed: 30456308

Auteurs

Yongjun Liu (Y)

Department of Pathology and Laboratory MedicineUniversity of Wisconsin School of Medicine and Public HealthMadisonWisconsinUSA.

David P Al-Adra (DP)

Department of SurgeryUniversity of Wisconsin School of Medicine and Public HealthMadisonWisconsinUSA.

Ruoxin Lan (R)

Department of Biostatistics and Data ScienceTulane University School of Public Health and Tropical MedicineNew OrleansLouisianaUSA.

Geunyoung Jung (G)

Department of Pathology and Laboratory MedicineUniversity of Wisconsin School of Medicine and Public HealthMadisonWisconsinUSA.

Huihua Li (H)

Department of Pathology and Laboratory MedicineUniversity of Wisconsin School of Medicine and Public HealthMadisonWisconsinUSA.

Matthew M Yeh (MM)

12353Department of Laboratory Medicine and PathologyUniversity of Washington School of MedicineSeattleWisconsinUSA.

Yao-Zhong Liu (YZ)

Department of Biostatistics and Data ScienceTulane University School of Public Health and Tropical MedicineNew OrleansLouisianaUSA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH